← 返回產品資料庫

⚠️ 此醫材許可證已註銷

狀態:已註銷 日期:2012/11/27

原因:許可證已逾有效期

"亞特斯" 癌胚胎抗原放射免疫分析試劑

🩺 醫材

"Adaltis" CEA Bridge

衛署醫器輸字第016308號

GDP 認證供應商

醫材分類

2 等級
  • C.6010腫瘤相關抗原免疫試驗系統

醫器規格

#14664: 120 tubes

限制項目

輸 入;;輸入須附同意書(每次輸入均須取得原子能委員會之同意書為憑)

適應症

用來檢測人體血清、血漿檢體中癌胚胎抗原(CEA)的含量。

醫材資訊

主成分
1. CEA Bridge Coated Tubes: 120 tubes; each carton box contains 60 tubes, packed in a plastic bag, coated with mouse monoclonal antibody to CEA.\n2. CEA Bridge Tracer: 1 vial/25 ml; containing lyophilized I-125 labelled mouse monoclonal antibody to human CEA. Maximum Radioactivity: 848 kBq per vial. The vial contains phosphate-citrate buffer with bovine serum albumin, sheep and mouse serum.\n3. CEA Bridge Calibrators: 5 vials; the vials contain respectively: 0, 20, 80, 320, 1280 mIU (0, 1, 4, 16, 64 ng) of CEA per ml, (1st IRP 73/601) horse serum with sodium azide \n4. Coated Tube Wash Concentrate: 1 vial containing an aqueous solution of Triton X-100 8 ml.\n5. CEA Normal Control: 1 vial containing lyophilized human serum with sodium azide <0.1%\n6. CEA Pathological Control: 1 vial containing lyophilized human serum with sodium azide <0.1%\n7. CEA Diluent: 1 vial containing horse serum and sodium azide <0.1%\n
製造商
ADALTIS ITALIA S.P.A.
製造國
IT
申請商
泰歷藥品儀器股份有限公司
有效日期
2011/04/06
發證日期
2006/04/06

供應藥局

目前尚無登錄供應此品項的藥局資料。